ASP Isotopes Inc (ASPI) Risk Assessment: Volatility, Financial Risk & Investment Risk

ASP Isotopes Inc received a risk assessment score of 2.85, ranking 111th among 155 pharmaceutical companies. The report highlights high volatility with a beta of 3.41 and a 240-day maximum drawdown of 73.13%.